BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 38507431)

  • 1. Association between smoking and lack of HIV virological suppression in a cross-sectional study of persons with HIV on antiretroviral therapy in Uganda.
    Tumwegamire A; Fatch R; Emenyonu NI; Lodi S; Muyindike WR; Kekibiina A; Adong J; Ngabirano C; Beesiga B; Marson K; Golabi N; Kamya M; Chamie G; Hahn JA
    PLoS One; 2024; 19(3):e0300508. PubMed ID: 38507431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculin skin test positivity among HIV-infected alcohol drinkers on antiretrovirals in south-western Uganda.
    Muyindike WR; Fatch R; Cheng DM; Emenyonu NI; Ngabirano C; Adong J; Linas BP; Jacobson KR; Hahn JA
    PLoS One; 2020; 15(7):e0235261. PubMed ID: 32614873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations Between Alcohol Use, Antiretroviral Therapy Use, and Viral Load Suppression Among People Living with HIV in Rural Central Uganda.
    Wynn A; Sileo KM; Schmarje Crockett K; Naigino R; Ediau M; Menzies NA; Kalichman SC; Wanyenze RK; Martin NK; Kiene SM
    AIDS Behav; 2024 Jul; 28(7):2205-2215. PubMed ID: 38775856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
    Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
    BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and viral suppression among people living with HIV from the National Free Antiretroviral Therapy Programme, 2019.
    Zhao Y; Han MJ; Gan XM; Ma Y; Zhao DC
    HIV Med; 2020 Dec; 21(11):701-707. PubMed ID: 33369034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained virological response and drug resistance among female sex workers living with HIV on antiretroviral therapy in Kampala, Uganda: a cross-sectional study.
    Namale G; Kamacooko O; Bagiire D; Mayanja Y; Abaasa A; Kilembe W; Price M; Ssemwanga D; Lunkuse S; Nanyonjo M; Ssenyonga W; Mayaud P; Newton R; Kaleebu P; Seeley J
    Sex Transm Infect; 2019 Sep; 95(6):405-411. PubMed ID: 31266818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of viral load monitoring and viral suppression under Treat All in Rwanda - a cross-sectional study.
    Ross J; Ribakare M; Remera E; Murenzi G; Munyaneza A; Hoover DR; Shi Q; Nsanzimana S; Yotebieng M; Nash D; Anastos K;
    J Int AIDS Soc; 2020 Jun; 23(6):e25543. PubMed ID: 32536033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alcohol Use and HIV Disease Progression in an Antiretroviral Naive Cohort.
    Hahn JA; Cheng DM; Emenyonu NI; Lloyd-Travaglini C; Fatch R; Shade SB; Ngabirano C; Adong J; Bryant K; Muyindike WR; Samet JH
    J Acquir Immune Defic Syndr; 2018 Apr; 77(5):492-501. PubMed ID: 29303844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study.
    Bahemana E; Esber A; Dear N; Ganesan K; Parikh A; Reed D; Maganga L; Khamadi S; Mizinduko M; Lwilla A; Mkondoo D; Mwaisanga G; Somi N; Owouth J; Maswai J; Kiweewa F; Iroezindu M; Ake JA; Crowell TA; Valcour VG; Polyak CS;
    AIDS Res Ther; 2020 Nov; 17(1):66. PubMed ID: 33183355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High viral suppression and low attrition in healthy HIV-infected patients initiated on ART with CD4 above 500 cells/µL in a program setting in Uganda.
    Byonanebye DM; Semitala FC; Katende J; Bakenga A; Arinaitwe I; Kyambadde P; Musinguzi P; Biraro IA; Byakika-Kibwika P; Kamya MR
    Afr Health Sci; 2020 Mar; 20(1):132-141. PubMed ID: 33402901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the interaction between depressive symptoms and alcohol use prior to antiretroviral therapy on viral suppression among people living with HIV in Rural Uganda.
    Foley JD; Sheinfil A; Woolf-King SE; Fatch R; Emenyonu NI; Muyindike WR; Kekibiina A; Ngabirano C; Samet JH; Cheng DM; Hahn JA
    AIDS Care; 2020 Oct; 32(10):1251-1257. PubMed ID: 32482097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort.
    Martinson NA; Gupte N; Msandiwa R; Moulton LH; Barnes GL; Ram M; Gray G; Hoffmann C; Chaisson RE
    PLoS One; 2014; 9(5):e96369. PubMed ID: 24831447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Universal test and treat is not associated with sub-optimal antiretroviral therapy adherence in rural South Africa: the ANRS 12249 TasP trial.
    Iwuji C; McGrath N; Calmy A; Dabis F; Pillay D; Newell ML; Baisley K; Porter K
    J Int AIDS Soc; 2018 Jun; 21(6):e25112. PubMed ID: 29890048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High rates of viral suppression in adults and children with high CD4+ counts using a streamlined ART delivery model in the SEARCH trial in rural Uganda and Kenya.
    Kwarisiima D; Kamya MR; Owaraganise A; Mwangwa F; Byonanebye DM; Ayieko J; Plenty A; Black D; Clark TD; Nzarubara B; Snyman K; Brown L; Bukusi E; Cohen CR; Geng EH; Charlebois ED; Ruel TD; Petersen ML; Havlir D; Jain V
    J Int AIDS Soc; 2017 Jul; 20(Suppl 4):21673. PubMed ID: 28770596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral suppression among children and their caregivers living with HIV in western Kenya.
    Humphrey JM; Genberg BL; Keter A; Musick B; Apondi E; Gardner A; Hogan JW; Wools-Kaloustian K
    J Int AIDS Soc; 2019 Apr; 22(4):e25272. PubMed ID: 30983148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful antiretroviral therapy delivery and retention in care among asymptomatic individuals with high CD4+ T-cell counts above 350 cells/μl in rural Uganda.
    Jain V; Byonanebye DM; Amanyire G; Kwarisiima D; Black D; Kabami J; Chamie G; Clark TD; Rooney JF; Charlebois ED; Kamya MR; Havlir DV;
    AIDS; 2014 Sep; 28(15):2241-9. PubMed ID: 25022596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. U.S. trends in antiretroviral therapy use, HIV RNA plasma viral loads, and CD4 T-lymphocyte cell counts among HIV-infected persons, 2000 to 2008.
    Althoff KN; Buchacz K; Hall HI; Zhang J; Hanna DB; Rebeiro P; Gange SJ; Moore RD; Kitahata MM; Gebo KA; Martin J; Justice AC; Horberg MA; Hogg RS; Sterling TR; Cescon A; Klein MB; Thorne JE; Crane HM; Mugavero MJ; Napravnik S; Kirk GD; Jacobson LP; Brooks JT;
    Ann Intern Med; 2012 Sep; 157(5):325-35. PubMed ID: 22944874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker-Measured Unhealthy Alcohol Use in Relation to CD4 Count Among Individuals Starting ART in Sub-Saharan Africa.
    Magidson JF; Fatch R; Orrell C; Amanyire G; Haberer JE; Hahn JA;
    AIDS Behav; 2019 Jun; 23(6):1656-1667. PubMed ID: 30560484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    Szubert AJ; Prendergast AJ; Spyer MJ; Musiime V; Musoke P; Bwakura-Dangarembizi M; Nahirya-Ntege P; Thomason MJ; Ndashimye E; Nkanya I; Senfuma O; Mudenge B; Klein N; Gibb DM; Walker AS;
    PLoS Med; 2017 Nov; 14(11):e1002432. PubMed ID: 29136032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.